Journal News

SUMO and stem cells

How protein modifications maintain pluripotency
Courtney Chandler
Feb. 1, 2022

Stem cells are like master cells — they can divide to create more stem cells and be triggered by signals within and outside of themselves to give rise to virtually any cell type in the body. In order to exist as precursors, in what is called the pluripotent state, stem cells must be tightly controlled by internal signals but also highly responsive to developmental cues. Researchers do not yet understand this balance completely.

A team from the University of Dundee in Scotland led by Barbara Mojsa recently investigated how stem cells are influenced by SUMOylation, a post-translational modification in which a small ubiquitinlike modifier called SUMO is attached to a lysine residue on target proteins. Their work recently was published in the journal Molecular & Cellular Proteomics.

The SUMOylation and deSUMOylation processes are reversible and dynamic and can affect cell fate by altering protein function, interactions or stability. The group previously was studying SUMOylation in cancer cells but decided they may not be the best model system due to the numerous mutations they contain.

“Stem cells are much more dynamic, require tighter control of all cellular processes and undergo dramatic changes during differentiation,” Mojsa said, “making them ideal to study the biological role of SUMOylation.”

The researchers started using human induced pluripotent stem cells instead. These hiPSCs are derived from terminally differentiated somatic cells such as blood or skin cells that have been reprogrammed back into a pluripotent state.

The group blocked SUMOylation in hiPSCs using an inhibitor called ML792 and found that key pluripotency markers were lost. They next engineered cells to express modified versions of two enzymes, SUMO1 and SUMO2, to identify which proteins were modified and where.

They identified 427 SUMO-modified proteins and 976 SUMO sites in hiPSCs and used bioinformatic tools to identify networks of proteins that were SUMOylated. They found that the majority of the protein targets were involved in regulating transcription and chromatin structure, both of which influence gene expression.

Courtesy of Barbara Mojsa & Ronald Hay
Network analysis of SUMO substrates identified in human induced pluripotent stem cells. 

“Delicate balance of SUMO modification might be the key to maintenance of pluripotent state and control of various differentiation processes,” Mojsa said.

The team’s technique also allowed them to differentiate between SUMO1 and SUMO2 targets.

“We didn’t expect to observe such a big difference between SUMO1 and SUMO2 targets,” Mojsa said. “It was previously suggested that these two proteins are rather redundant in their functions.”

This research has impacts beyond understanding what forces control the pluripotent state. The ML792 inhibitor recently entered clinical trials for cancer treatment —understanding its broader effect is informative. Furthermore, hiPSCs can be used to generate almost any human cell type and therefore could have therapeutic uses. However, the process to differentiate the cells can be lengthy.

“If what we think is true and SUMOylation acts as a brake to cell differentiation, we could imagine using SUMOylation inhibitors to increase the efficiency or shorten the time required for differentiation, which would be a great advantage for regenerative medicine,” Mojsa said.

In the future, the group is interested in understanding how SUMOylation affects differentiation pathways.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a careers columnist for ASBMB Today.

Related articles

From the journals: MCP
Vanshika Patel
From the journals: MCP
Meric Ozturk
From the journals: MCP
Courtney Chandler

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

CRISPR epigenome editor offers potential gene therapies
News

CRISPR epigenome editor offers potential gene therapies

April 25, 2025

Scientists from the University of California, Berkeley, created a system to modify the methylation patterns in neurons. They presented their findings at ASBMB 2025.

Finding a symphony among complex molecules
Profile

Finding a symphony among complex molecules

April 23, 2025

MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

E-cigarettes drive irreversible lung damage via free radicals
Journal News

E-cigarettes drive irreversible lung damage via free radicals

April 17, 2025

E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.

Using DNA barcodes to capture local biodiversity
ASBMB Annual Meeting

Using DNA barcodes to capture local biodiversity

April 15, 2025

Undergraduate at the University of California, Santa Barbara, leads citizen science initiative to engage the public in DNA barcoding to catalog local biodiversity, fostering community involvement in science.

Targeting Toxoplasma parasites and their protein accomplices
Journal News

Targeting Toxoplasma parasites and their protein accomplices

April 11, 2025

Researchers identify that a Toxoplasma gondii enzyme drives parasite's survival. Read more about this recent study from the Journal of Lipid Research.

Scavenger protein receptor aids the transport of lipoproteins
Journal News

Scavenger protein receptor aids the transport of lipoproteins

April 11, 2025

Scientists elucidated how two major splice variants of scavenger receptors affect cellular localization in endothelial cells. Read more about this recent study from the Journal of Lipid Research.